摘要
关于药品说明书的著作权保护问题,我国理论界与实务界争论已久。药品说明书的独创性和合理使用问题,在澳大利亚司法实践中同样引起争议。有必要评介2011年澳大利亚Sanofi-Aventis公司案关于药品说明书独创性、默示许可方面的判决,分析Sanofi-Aventis公司案之得失,探索我国药品说明书著作权保护的合理路径。
The issues such as whether the product information of medicine is original and therefore should be protected by the Copyright Law has been discussed for a long time both in the practical and theoretical fields in China. It is necessary to analyze the disputes in the 2011 Australia "Sanofi-Aventis "' Company Case, review the judgement on the originality and implied license of the case, and search for the reasonable approach to the copyright protection of the product information of medicine.
出处
《西安电子科技大学学报(社会科学版)》
CSSCI
2013年第2期117-123,共7页
Journal of Xidian University:Social Science Edition
基金
教育部人文社科基地重大课题"二十一世纪国际知识产权制度发展中的若干重大法律问题研究"(07JJD820163)子课题之三"国际知识产权制度与保护公共健康的若干法律问题"的部分成果
关键词
药品说明书
独创性
著作权
Information of medicine product
Originality
Copyright